Navigation Links
Labopharm amends debt facility agreement with Hercules
Date:6/25/2009

structuring of the Canadian asset-backed commercial paper, which amount the Company can, under certain conditions, repay at maturity by delivering the notes to the bank.

About Labopharm Inc.

Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily formulation of tramadol, is now available in 17 countries around the world, including the U.S., Canada, major European markets, and Australia, among others. The Company's second product, a novel formulation of trazodone for the treatment of major depressive disorder, is under regulatory review by the FDA. The Company also has a robust pipeline of follow-on products in both pre-clinical and clinical development. Labopharm's vision is to become an integrated, international, specialty pharmaceutical company with the capability to internally develop and commercialize its own products. For more information, please visit www.labopharm.com.

This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein and depend on a number of factors, including the uncertainties related to the regulatory process in various countries for the approval of the Company's products and the successful commercialization of the products throughout the world if they are approved. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.

'/>"/>

SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
2. Labopharm Reports Results for First Quarter Fiscal 2009
3. Labopharm announces details for first quarter results conference call and annual meeting
4. Labopharm reports results for Phase III study on twice-daily tramadol-acetaminophen formulation
5. Labopharm to present at Cowen 29th Annual Health Care Conference
6. Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008
7. Labopharm to host conference call Thursday, February 26, 2009 at 8:30 a.m. (ET)
8. Labopharm to host conference call to discuss FDA approval of once-daily RYZOLT(TM) on Tuesday, January 6, 2009 at 8:30 a.m. (ET)
9. Labopharm Announces FDA Approval of Once-Daily RYZOLT(TM) (Tramadol HCL Extended Release Tablets) for Management of Moderate to Moderately Severe Chronic Pain
10. Labopharm to host webcast presentation on novel trazodone formulation - tomorrow (Dec.16/08) at 10:00 a.m. ET
11. Labopharm Comments on Recent Trading Activity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2014)... report, "Phthalic Anhydride and Derivatives (Plasticizers, Unsaturated Polyester Resins, ... Trends & Forecast to 2018," defines and segments phthalic ... and value. The report also estimates the demand and ... anhydride is projected to grow from an estimated $6,130.55 ... a CAGR of 5.24% from 2013 to 2018. , ...
(Date:7/12/2014)... The "North American ... Market by Angioplasty Balloon (Plain/Old, Cutting), ... IVC Filter (Retrievable), Endovascular Stent Graft ... studies the major market drivers, restraints, ... Canada. , Browse 108 market data ...
(Date:7/12/2014)... Demand Response Management Systems is a crucial peak ... imbalance between energy supply and demand. With the help ... (due to increasing pressure on the grid) and replaced ... residential appliances and thermostats for load reduction. , ... and with government mandates and benefits for energy efficiency ...
(Date:7/12/2014)... The fastest-growing mobile technology is LTE ... of LTE networks continues to grow due to the ... have increased mobile data traffic, which is a major ... Communications Test and Measurement equipment comply with industry standards, ... Test and Measurement Market is estimated to grown from ...
(Date:7/12/2014)... Casinos in Australia have grown ... international and online casinos. Revenue is estimated to increase ... through 2014-15. Greater per capita gambling expenditure has assisted ... in discretionary income levels have also assisted revenue growth, ... such as casino gambling services. Revenue is estimated to ...
Breaking Medicine News(10 mins):Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 2Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 3Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 2Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 5Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 4Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 4Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 5Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 4
... in Most Categories of Customer ... Satisfaction, According to MD Buyline, ... industry-leading provider of Computer-Aided Detection (CAD),solutions for the early ... record-high customer satisfaction ratings in the,Mammography CAD market, according ...
... Releasing Second Quarter 2008 Financial Results on Tuesday, July 29, ... Healthcare 2008 Investor ... on Tuesday, August 5, 2008, CINCINNATI, July 10 ... services under the,LasikPlus brand, announced today upcoming investment community events., ...
... muscle in mice, researchers report , , THURSDAY, July ... managed to repair damaged muscle in mice with a ... stem cells from skeletal muscle. , There,s no guarantee ... disease, said study author Amy Wagers, an assistant professor ...
... as pain killers are packaged today in cylindrical tubes ... of desiccant to protect the contents against moisture, while ... from rattling around. , However, such caps often fall ... to manipulate. Customers and,suppliers of vitamin pills and similar ...
... July 10 Merit Medical,Systems, Inc. (Nasdaq: ... disposable devices used primarily in cardiology and radiology,procedures, ... ended June,30, 2008 were approximately $57.4 million, an ... which the Company believes will produce earnings in,the ...
... Purpledogtag.com Offers Easy Way for Every American to Stand Behind Our ... ... Ron Lawner,s Catalyst (RLC),a company focused on creating awareness for the ... its first,campaign, Purple Dog Tag. The project,s goal is to assist those ...
Cached Medicine News:Health News:iCAD Achieves Record-High Ratings in Mammography CAD User Satisfaction 2Health News:iCAD Achieves Record-High Ratings in Mammography CAD User Satisfaction 3Health News:LCA-Vision Announces Upcoming Investment Community Events 2Health News:Stem Cells Hold Promise for Muscular Dystrophy 2Health News:Integrated tube cap design simplifies access to medication 2Health News:Merit Medical Pre-Announces Record Sales and Earnings for the Second Quarter Ended June 30, 2008 2Health News:Merit Medical Pre-Announces Record Sales and Earnings for the Second Quarter Ended June 30, 2008 3Health News:Purple Dog Tag Launches; Provides Hope and Healing to Thousands of US Servicemen & Veterans 2
(Date:7/10/2014)... July 10, 2014  Decision Resources Group finds ... disease (ID) specialists are willing to prescribe Durata,s ... for use as OPAT, approximately two-thirds of the ... to their hospital inpatients. However, our findings indicate ... are initiated on OPAT following hospital discharge, and ...
(Date:1/15/2014)... Jan. 15, 2014 Sono-Tek Corporation (OTC BB: SOTK) today ... 30, 2013, compared to sales of $2,202,000 for the prior ... this quarter has also shown growth over the preceding quarter,s ... of this fiscal year. Markets that experienced sales increases over ...
(Date:1/15/2014)... Jan. 15, 2014 As health officials across the Midwest ... Meijer pharmacies in Michigan will offer ... patients, enabling Meijer pharmacists to administer tests and, in some ... a physician participating in the study. The ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
... Reportlinker.com announces that a new market ... Generic Drugs: The Global ... http://www.reportlinker.com/p0619265/Generic-Drugs-The-Global-Market--Focus-on-Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Machine_Tool_and_Equipment THIS REPORT ... of the strategies employed by companies specializing ...
... AAIPharma Services Corp., a leading provider of ... an online quote generation and sample submission service ... Available 24 hours a day, seven days a ... accurate submissions with the convenience of Internet access. ...
Cached Medicine Technology:Generic Drugs: The Global Market--Focus on Europe 2Generic Drugs: The Global Market--Focus on Europe 3Generic Drugs: The Global Market--Focus on Europe 4Generic Drugs: The Global Market--Focus on Europe 5Generic Drugs: The Global Market--Focus on Europe 6Generic Drugs: The Global Market--Focus on Europe 7Generic Drugs: The Global Market--Focus on Europe 8Generic Drugs: The Global Market--Focus on Europe 9Generic Drugs: The Global Market--Focus on Europe 10AAIPharma Services Announces 24/7 Online Compendial Raw Materials Testing 2
... the outstanding features of our Neomax Premium ... Technology. , This manufacturing process allows us ... the bunching and irritation in the popliteal ... , ,Colors available: Blue, Black. ...
... a convenient, reusable, patient-friendly and effective ... orthopedic conditions/instabilities. These products are designed ... lateral to medial influence of cutaneous ... and soft tissue structures. Maximum benefit ...
... lightweight, low profile, custom knee brace designed ... Tested by top professionals, this sport-specific C.Ti.2 ... is optimized,for athletes with large Vastus Medialis ... lateral arms are engineered with,a slight degree ...
The Deluxe Knee Immobilizer provides superb lightweight immobilization following injury or surgery. It is available in a wide array of sizes for excellent comfort and fit....
Medicine Products: